Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To assess whether urea-based cream (UBC) has prophylactic benefits on sorafenib-induced hand-foot skin reaction (HFSR) in patients with advanced hepatocellular carcinoma (HCC).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Clin. Oncol.

Title: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

ISSN (Electronic): 1527-7755

ISSN (Print): 0732-183X

Publication date (Electronic): Mar 10 2015

Volume: 33

Issue: 8

Affiliations

[1 ] ZhengGang Ren and Sheng-Long Ye, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education; ZengQiang Qu, WeiPing Zhou, and LeHua Shi, Eastern Hepatobiliary Surgery Hospital of the Second Military Medical University, Shanghai; KangShun Zhu and MinQiang Lu, The Third Affiliated Hospital of Sun Yat-sen University; LiGong Lu, Guangdong Provincial People's Hospital, Guangdong; HaiYan Kang, 301 Military Hospital; YongPing Yang, 302 Military Hospital; XiaoFeng Guo, Chinese Anti-Cancer Association, Beijing; TianQiang Song, Tianjin Cancer Hospital, Tianjin; Hui Wang, Jilin Provincial Tumor Hospital, Jilin; WeiZhu Yang, Union Hospital of Fujian Medical University, Fujian; Xuan Wang, The 81 Hospital of the Chinese People's Liberation Army, Nanjing; and YuXian Bai, Heilongjiang Provincial Cancer Hospital, Heilongjiang, People's Republic of China.

[2 ] ZhengGang Ren and Sheng-Long Ye, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education; ZengQiang Qu, WeiPing Zhou, and LeHua Shi, Eastern Hepatobiliary Surgery Hospital of the Second Military Medical University, Shanghai; KangShun Zhu and MinQiang Lu, The Third Affiliated Hospital of Sun Yat-sen University; LiGong Lu, Guangdong Provincial People's Hospital, Guangdong; HaiYan Kang, 301 Military Hospital; YongPing Yang, 302 Military Hospital; XiaoFeng Guo, Chinese Anti-Cancer Association, Beijing; TianQiang Song, Tianjin Cancer Hospital, Tianjin; Hui Wang, Jilin Provincial Tumor Hospital, Jilin; WeiZhu Yang, Union Hospital of Fujian Medical University, Fujian; Xuan Wang, The 81 Hospital of the Chinese People's Liberation Army, Nanjing; and YuXian Bai, Heilongjiang Provincial Cancer Hospital, Heilongjiang, People's Republic of China. slye@shmu.edu.cn.

Article

Publisher Item ID: JCO.2013.52.9651

DOI: 10.1200/JCO.2013.52.9651

PubMed ID: 25667293

SO-VID: e52075a4-0057-4c62-923d-64bd8ab754c0

History

Data availability:

Comments

Comment on this article

scite_

Cited by 41

See all cited by